Therapeutic Advances in Cardiovascular Disease: 2020, vol: 14, issue:
1)- Christina Paitazoglou, Martin W Bergmann. The atrial flow regulator: current overview on technique and first experience.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720919577
2)- Mikayla Muzzey, Katie B Tellor, Karthik Ramaswamy, Martin Schwarze, Anastasia L Armbruster. Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective study.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720926824
5)- Athar Ansari, Moiz Ali Shah, Manaim Amir Shah, Zahra Ansari. Safety of day-case endovascular interventions for peripheral arterial disease in a rural, underserved area.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720948651
6)- . Corrigendum to gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720956752
8)- Virna Margarita Martín Giménez, León Ferder, Felipe Inserra, Joxel García, Walter Manucha. Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720977715
9)- Neil Ruparelia, Vasileios Panoulas. The missing acute coronary syndromes in the COVID-19 era.Therapeutic advances in cardiovascular disease. 2020, 14: 1753944720977732